chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient is an 86 year old  male with a history of HFpEF, Hypertension, COPD, CAD s/p CABG, Lung Cancer s/p RUL lobectomy, Arthritis on chronic steroids, who presented to Hospital Observation 8/30/2023 with 3 weeks of cough, diarrhea, generalized weakness and found to have COVID-19 infection.      1. COVID-19: s/p vaccination. Symptoms onset ~3 weeks prior to presentation with cough, diarrhea, nausea. Positive test date 8/30/23.  Evaluated by pulmonology, no indication  for Remdesivir or decadron.  Discharged on 2L O2 NC. 2. Acute Respiratory Failure with Hypoxia: In setting of above, no baseline oxygen requirements. Evaluated by Pulmonology. Discharged on as needed home oxygen, was requiring 1-2L O2.  3. AKI on CKD stage 3b: baseline Cr ~1.8 Admit Cr 2.2. Suspected pre-renal in setting of COVID19, poor PO intake, complicated by ACE Inhibitor/Loop diuretic. Reduced home lasix dose at discharge.  Creatinine 1.79 at discharge. 4. Elevated Right Hemidiaphragm: in setting of prior RUL lobectomy. Admit Chest X-ray with elevated right hemidiaphragm unchanged from 2017. 5. HFpEF: per history. TTE (7/2019) with G1DD, LVEF 65%. Hypovolemic on admission. Continued home meds, reduced dose of lasix at 20mg BID at discharge.   6. Hypertension: Continued home meds. 7. CAD: per history. s/p CABG (2015). Continued home medications.  8. COPD: per history. Follows with Dr. (Pulmonology). No evidence of exacerbation on admission. 9. History of  Lung Malignancy: s/p RUL lobectomy (2012).  10. T2DM: Continued home meds. 11. Polymyalgia Rheumatica/Arthritis: follows with Dr. (Rheum). Continued home chronic low-dose Prednisone
My first dose was administered on August 14, 2021 when I was on my first day of my cycle. The second dose was administered on 9/4/21 when I was on day 22 of my cycle and 10 days past ovulation. On September 8, I received a positive home pregnancy test. On September 20, I was diagnosed with a nonviable pregnancy of unknown location with slow-rising HCG patterns. Due to life-threatening implications, methotrexate had to be adminsitered
I received the second dose of my Moderna covid vaccine at 10 am on Wednesday February 3rd. Around 8:30 pm I experienced extreme chills and had a 100-101 F fever all night. I woke in the morning still feeling weak because I spent the whole night uncomfortable from the fever and flushed  face I had. I walked towards another part of my house and fell down and fainted. I was unconscious for a few seconds before a family member was able to shake me and wake me up. I take no medications and am a generally healthy individual with no prior medical history or underlying Heath conditions. I also do not have a history of falls or issues from taking any past vaccines. I also am not allergic to anything or have experienced any allergic reactions in my life. It?s the second day now and I am still experiencing a 100 Degree fever and face flushing. I am currently self medicating at home with Tylenol every 4-6 hours. I have not gone to see a health care professional yet.
Mild chest pain,, under left arm and in shoulder starting morning of 08/31/2021. Diagnosis = idiopathic pericarditis. Treatment = high dose aspirin + colchicine.
After 10-13 minutes, patient began walking  towards the front of the store.  Mother reports that patient fainted in the aisle.  Mom caught patient to and prevents her from hitting her head.  Mom escorted patient back to the pharmacy area where sh remained seated and monitored for an additional 15 minutes.  Patient was given water and her blood pressure was later taken and found to be within normal range.  When she was feeling well, patient left with her mother.
It was reported that a male pt received Fluzone SV '00-'01 vaccination on 12/5/00. Approx. 3 days, post vax, pt developed "flu-like" symptoms. Pt was admitted to the hospital on 12/10/00. Pt expired on 12/18/00 and an autopsy was done, results not provided. Further information requested. Autopsy also states patient had headaches, muscle aches, diarrha, nausea, vomiting, fever, cough, sore throat, abdominal pain.
I awoke the day after 2nd  vaccine with both shoulders and both elbows on fire. While very uncomfortable, I didn?t want to take any pain med and perhaps interfere with whatever the shot was doing to give me protection.  I had an incident during that day in which my puppy bolted out the door and I reached very quickly to grab him. As I did so, I heard and felt a loud SNAP in my (left) shoulder and my arm hung at my side for most of the rest of the day.  By early evening, I could use it mostly, but not fully.  And the fire in my affected joints began to subside. By morning the fire was gone and a dull ache dissipated during the day.  I did not go to my Dr at the time, but I reported my experience to her at a later date during a routine check-up.
Patient noticed that she had a rash when she got out of the shower this morning. Rash is only on the top part of the chest/bottom of neck.  She is taking Benadryl to decrease itching.  Rash has not spread or caused any trouble breathing.
No adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 64-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 05822-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Aug-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 18-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients).    Concomitant medication was not provided.  It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was reported that 77 Monovalent doses administered after the BUD to patients 12 and up.12 doses from Lot 058A22-2A were administered.  Treatment information was not provided.
Admitted to hospital for drowsiness, dx with encephalitis.   12/15/09 VHC records received. Service date 12/15/09. Assessment: Upper respiratory infection. Vasovagal Syncope. Atopic Eczematous Dermatitis. Patient was nauseous, intestinal cramping, dry heaves, light headed, diaphoretic, and pale. Decreased BP, unable to stay conscious. Blacked out, fell, and hit head. Hospitalized with Dx of flu, released from hospital, still has flu symptoms. Mild headache, neck discomfort. Nausea, myalgias, 'lawnmower sound' in right ear.  Tinnitis, nasal discharge, nasal passage blockage, sore throat. Rash, patches of dry scaling skin on shoulders and arms. Laceration on forehead.
Pt given VARICELLA vaccine 1/30/2017 and developed an oblong shaped (3cm x 5cm) indurated area of redness at site of injection within 24 hours of injection. No treatment necessary.
Approx 12 hours post vaccination became dizzy but didn't faint, experienced chest pain, and nauseated.
At day 9 or 10 after the first vaccine my arm around the site of the injection became red, warm, itchy and a little swollen. The area of the redness in my arm increased in size for the next few days.  Now at day 17 following the first injection, the redness is beginning to diminish. The sensitivity of that area is still apparent. I applied a skin moisturizer on the affected area.
A report has been received from a Pharmacist concerning a 7 year old patient of unknown gender, who had been receiving Nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown date. Child has been vaccinated against the flu in the past. Administration followed appropriate procedure as described where half the dose was administered into one nostril and then the 2nd half after divider was removed was administered into the 2nd nostril. After it was administered into the 2nd nostril, dripping out of the nose occurred (a stream). The outcome of the event of leakage of vaccine out of one nostril was unknown. The reporter's description of the event(s) was as follows: Not on any other medications. The report was considered to be non-serious.
We have some Moderna Covid-019 vaccine that was given after the expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    In October 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.). In October 2021, EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided.  No treatment medications provided.
pt was here for her 2nd covid dose of pfizer vaccine; immunizing technician accidentally gave pt johnson and johnson janssen vaccine; pt was notified; pt reported no problems
shingles rash/Suspected vaccination failure; shingles rash; itchy scalp; tingling around left eye; sensitivity of nerves on forehead; tingling around left eye socket; swollen left eye/eye was closed shut; Sty; headache; This serious case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number 524S7, expiry date 12-FEB-2021) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 19-JAN-2019, the patient received the 2nd dose of Shingrix. On 30-SEP-2018, the patient received the 1st dose of Shingrix. On 10-AUG-2023, 1664 days after receiving Shingrix and 1775 days after receiving Shingrix, the patient experienced eye swelling (Verbatim: swollen left eye/eye was closed shut). In AUG-2023, the patient experienced stye (Verbatim: Sty) and headache (Verbatim: headache). On an unknown date, the patient experienced vaccination failure (Verbatim: shingles rash/Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: shingles rash), itchy scalp (Verbatim: itchy scalp), eye paresthesia (Verbatim: tingling around left eye), hyperesthesia (Verbatim: sensitivity of nerves on forehead) and tingling (Verbatim: tingling around left eye socket).The patient was treated with valaciclovir hydrochloride (Valtrex), prednisone, ophthalmologicals (nos) (Eye Drops (Ingredients Unknown)) and antibiotics nos (Antibiotics (Brand Names Not Known)). The outcome of the vaccination failure was unknown and the outcome of the shingles, stye, headache and eye swelling were resolved and the outcome of the itchy scalp, eye paresthesia, hyperesthesia and tingling were not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, stye, headache, itchy scalp, eye paresthesia, hyperesthesia, eye swelling and tingling to be related to Shingrix and Shingrix.   It was unknown if the company considered the vaccination failure, shingles, stye, headache, itchy scalp, eye paresthesia, hyperesthesia, eye swelling and tingling to be related to Shingrix and Shingrix.   Additional Information: GSK Receipt Date: 27-SEP-2023 The patient stated that she received Shingrix.  She stated that she experienced a swollen left eye and her eye doctor gave her eye drops and diagnosed her with a sty. A few days after that she started getting headaches and by 13th August 2023 her eye was closed shut. She went to emergency room. The healthcare professional prescribed antibiotics, Valtrex, Prednisone and eye drops.  She stated that she was down for a week and a half. Her symptoms had since resolved except she has itchy scalp, tingling around left eye socket and sensitivity of nerves on forehead.  She still used eye drops and Valtrex. ER (emergency visit) required. The reporter did not consent to follow-up.
Reaction  was either in my lymph nodes or bursa's that became inflamed in left elbow and left  knee.  To date (6-10-21) the elbow has gotten better, but, the knee has still remained swollen and painful.  4-20-21 Dr., Rheumatologist, removed fluid off left knee and gave me a cortisone shot.   First shot was given at fairgrounds.   Second shot was scheduled for 4-2-21 but,  deferred due to allergic reaction to first shot.  this has been indicated  on my vaccine card.   Please let me know if I need to provide any additional information.  Thank you
noticed egg-sized swelling 2hrs p/vax (swelling, lump & heat);by 5-6Pm swelling was down to elbow (6-7" induration); call to MD advised to start DPH;only applied ice from shoulder-elbow
An LPN who was doing a Covid Vaccine clinic administered  the 6mo-4yr strength of the PfizerBioNTech vaccine, when he should have received the 5 yr -11 yr strength
Information was received on 11-JUL-2017 from a licensed practical nurse who was reporting on multiple unspecified patients of unknown age and gender. No medical history or concomitant medications were reported. The nurse reported that on unspecified dates, an unspecified number of patients were administered unspecified separate doses of improperly stored doses of PROQUAD (lot # M038229, expires 06-MAR-2018 and N013865, expires 31-OCT-2018) and also an unspecified separate number of patients were administered doses of improperly stored VARIVAX (MARRS# 1707USA004636). The lot numbers of the sterile diluent used to reconstitute the vaccine were unknown. No adverse effects were reported. No other information was provided. The temperature excursion was 6 degrees F. to 14 degrees F. for 8 hours and 52 minutes and 30 seconds. This was due to data logger. Additional information has been requested. This is one of two reports by the same reporter.
COVID-19 vaccine administered after expiration. Vaccine expired 8/31/2022, administered 9/1/2022.
Chills, not feeling well, felt like she was getting sick lasted 2-3 days.
Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Patient received vaccines past its 30 days expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccines past its 30 days expiry date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022 at 2:04 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022 at 2:04 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccines past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccines past its 30 days expiry date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter. Vaccine was in thaw state (2 to 8 degree Celsius) from about 20-Dec-2021. No treatment medication was reported by reporter.   This case was linked to MOD-2022-542869 (Patient Link).
Severe migraine that persisted two days. Chills and sweating for two days. Nausea and vomiting for the two days after. Day three sever diarrhea  like straight liquid for most of the day.  Severe fatigue on day 4.
Stomach cramps; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach cramps) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach cramps). At the time of the report, ABDOMINAL PAIN UPPER (Stomach cramps) outcome was unknown. Not Provided          No concomitant medications were reported.  No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
3 days after injection, started lymph node swelling and pain under both armpits. This lasted for three days total and the next morning started having severe nerve pain/zings in my right cheek/jawbone area, into my ear and down my chin.  Three days of nerve pain, woke up early in morning with blisters on my lip and forming in my mouth.  Within two days, full outbreak of blisters.  Wen to urgent care on Friday the 28th, received diagnosis of shingles.  As of today, 1/31, am still recovering. Am on antivirals and am supplementing with vitamin C, b complex and lysine complex.
Information has been received from a physician concerning a female patient who was vaccinated with a dose of GARDASIL on an unspecified date. After receiving GARDASIL, the patient was developed HPV with a positive "pap" test. Physician unsure where patient was in series. The patient did not sought medical attention. At the time of report the patient's status was unknown. No further information is available.
Post vax, hospital employee developed cellulitis at the injection site.  The pt was treated with Keflex.
vaccines given post excursion, with no reported adverse event; Initial information received on 06-May-2022 regarding an unsolicited valid non-serious case received from a health professional.  This case involves a 4-year-old male patient for whom vaccines were given post excursion, with no reported adverse event while receiving vaccine diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccine [quadracel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included measles vaccine live (enders-edmonston), mumps vaccine live (jeryl lynn), rubella vaccine live (wistar ra 27/3), varicella zoster vaccine live (oka/merck) (proquad) for Immunisation.  On 03-May-2022, the patient received a dose of suspect diphtheria, tetanus, ac pertussis and ipv vaccine lot C5916AA with unknown dosage form, strength and expiration date via intramuscular route in the left deltoid for immunization.  On 03-MAY-2022 the patient developed a non-serious event of vaccines given post excursion, with no reported adverse event (product administration error) following the administration of diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccine.  Action taken with diphtheria, tetanus, ac pertussis and ipv vaccine (quadracel) was not applicable.  It was not reported if the patient received a corrective treatment for the event (vaccines given post excursion, with no reported adverse event).  At time of reporting, the outcome was Unknown for the event vaccines given post excursion, with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  01092869: 01092879: 01092814: 01092832: 01092891: 01092687: 01092746: 01092709: 01092741: 01092787: 01092803: 01092850:
Patient had a localized reaction at the injection site - redness and swelling area has been "hot" to touch and spreading.
received Havrix expired dose; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 32-year-old female patient who received HAV (Havrix) (batch number KM72C, expiry date 18th June 2022) for prophylaxis.   On 6th August 2022, the patient received Havrix. On 6th August 2022, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 08-AUG-2022 Reporter's Comments: The patient received Havrix expired dose. The reporter consented to follow up. Additional Supportive Information: The patient received Havrix expired dose which led to expired vaccine used.
Patient was under the age of 18 when he received his first dose of Moderna COVID vaccine  on 03/15/2021 shortly after 9:30am at Health Center. No adverse reactions where witnessed at the time of administration or during his 15min of observation, although the vaccine is has not been approved for anyone under 18 years of age.
Patient recieved the Pfizer Lot FP7137 ( which is a monovalent COVID-19 vaccine) for his booster instead of the Bivalent booster. He was made aware of this and can receive the booster bivalent shot after two months.
Pt reported feeling "hot & cold" immediately after receiving vacination; No headache, dizziness, nausea or difficulty breathing reported.
Pt was given 2 immunizations on 7/22/03. These were #2 MMR and #4 DTaP to right arm. Mom states that evening he was crying up until 11:00 PM. Today his arm is red, hot and swollen. Area involved measures 40mm x 40mm.
Received the vaccine on 12/31/20 at 1535 on the left arm. Swollen lymph node start on Friday 01/08/20 evening, around 2030 notice a lump on the left under armpit while doing self-breast exam during showering. On  01/09/20 the swollen increase, on 01/10/20 - 01/11/20 the swollen feel every painful, difficult, and comfortable when resting the left arm down, it feels like a golf ball under the armpit.  Felt numbness and tingling on the left arm, hand and fingesr.  On 01/12/20 lymph node still swollen, but less painful, with less numbness and tingling.    Home treatment: Elevated the left arm while applying a warm compress and OTC Tylenol.
Fever of 103 for 24 hours followed by full body rash for a week.